“…An array of different inflammation modifying regimens have recently been reported to inhibit or promote the incidence and/or rupture of AAAs formed in the different mouse models (Figure 2 and Table S1) (Amin et al, 2019;Hiromi et al, 2020;Krishna et al, 2019;Li, Nie, et al, 2019;Li, Xia, et al, 2019;Liu, Fitzgerald, et al, 2019;Liu, Kong, et al, 2019;Nie et al, 2019;Paige et al, 2019;Peshkova et al, 2019;Ren et al, 2020;Sharma, Dev, Belenchia, et al, 2019;Suehiro et al, 2019;Suh et al, 2020). The nucleotide-binding domain leucine-rich repeat (NLR) and pyrin domain-containing receptor 3 (NLRP3)-inflammasome plays an important role in innate immunity through controlling the secretion of pro-inflammatory cytokines.…”